AccuGenomics Email Format

Biotechnology ResearchNorth Carolina, United States2-10 Employees

AccuGenomics is a biotechnology research company that develops life science tools to improve the accuracy of next-generation sequencing in precision medicine. Its core offering, SNAQ-SEQ, is an internal quality control standard designed to be integrated into existing NGS workflows, enhancing sensitivity and specificity for diagnostics and monitoring, especially at low detection limits. This helps reduce inaccuracies in NGS results that can affect clinical decisions in areas like early detection and measurable residual disease. The company offers multiple products across oncology targets such as myeloid, CRC/NSCLC, ctDNA MRD, TP53, and breast cancer, plus custom internal standard mixtures, and it also supplies standards for pathogen testing and biomanufacturing QC. Based in Wilmington, North Carolina, AccuGenomics announced a strategic partnership with LGC Clinical Diagnostics in 2024 to develop NGS quality control materials.

Sign up for free to view info

Company overview Employee directory